HuGE Literature Finder
Records
1
-
17
| Determination of ERG(+), EZH2, NKX3.1, and SPINK-1 subtypes to evaluate their association with clonal origin and disease progression in multifocal prostate cancer. Cancer reports (Hoboken, N.J.) 2022 10 e1728. Segura-Moreno Yenifer Yamile, Sanabria-Salas María Carolina, Mesa-López De Mesa Jorge Andrés, Varela-Ramirez Rodolfo, Acosta-Vega Natalia Lizeth, Serrano Martha Luc |
| DNA Promoter Methylation and ERG Regulate the Expression of CD24 in Prostate Cancer. The American journal of pathology 2021 1 191 (4): 618-630. Tolkach Yuri, Zarbl Romina, Bauer Simone, Ritter Manuel, Ellinger Jörg, Hauser Stephan, Hüser Laura, Klauck Sabine M, Altevogt Peter, Sültmann Holger, Dietrich Dimo, Kristiansen Gl |
| Targeted next-generation sequencing for locally advanced prostate cancer in the Korean population. Investigative and clinical urology 2020 3 61 (2): 127-135. Suh Jungyo, Jeong Chang Wook, Choi Seongmin, Ku Ja Hyeon, Kim Hyeon Hoe, Kim Kwang Soo, Kwak Che |
| Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy. Oncotarget 2019 Aug 10 (48): 4973-4986. Schroeder Cornelia, Navid-Hill Elham, Meiners Jan, Hube-Magg Claudia, Kluth Martina, Makrypidi-Fraune Georgia, Simon Ronald, Büscheck Franziska, Luebke Andreas M, Goebel Cosima, Lang Dagmar S, Weidemann Sören, Neubauer Emily, Hinsch Andrea, Jacobsen Frank, Lebok Patrick, Michl Uwe, Pehrke Dirk, Huland Hartwig, Graefen Markus, Schlomm Thorsten, Sauter Guido, Höflmayer Dor |
| SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG-rearranged prostate cancer. The Prostate 2019 5 79 (10): 1156-1165. Hernández-Llodrà Silvia, Segalés Laura, Safont Ainara, Juanpere Nuria, Lorenzo Marta, Fumadó Lluís, Rodríguez-Vida Alejo, Cecchini Lluís, Bellmunt Joaquim, Lloreta-Trull Jos |
| Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer. Clinical epigenetics 2018 8 10 (1): 105. Storebjerg Tine Maj, Strand Siri H, Høyer Søren, Lynnerup Anne-Sofie, Borre Michael, Ørntoft Torben F, Sørensen Karina |
| Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression. European urology 2017 Sep . Ren Shancheng, Wei Gong-Hong, Liu Dongbing, Wang Liguo, Hou Yong, Zhu Shida, Peng Lihua, Zhang Qin, Cheng Yanbing, Su Hong, Zhou Xiuqing, Zhang Jibin, Li Fuqiang, Zheng Hancheng, Zhao Zhikun, Yin Changjun, He Zengquan, Gao Xin, Zhau Haiyen E, Chu Chia-Yi, Wu Jason Boyang, Collins Colin, Volik Stanislav V, Bell Robert, Huang Jiaoti, Wu Kui, Xu Danfeng, Ye Dingwei, Yu Yongwei, Zhu Lianhui, Qiao Meng, Lee Hang-Mao, Yang Yuehong, Zhu Yasheng, Shi Xiaolei, Chen Rui, Wang Yang, Xu Weidong, Cheng Yanqiong, Xu Chuanliang, Gao Xu, Zhou Tie, Yang Bo, Hou Jianguo, Liu Li, Zhang Zhensheng, Zhu Yao, Qin Chao, Shao Pengfei, Pang Jun, Chung Leland W K, Xu Jianfeng, Wu Chin-Lee, Zhong Weide, Xu Xun, Li Yingrui, Zhang Xiuqing, Wang Jian, Yang Huanming, Wang Jun, Huang Haojie, Sun Yingh |
| Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and Prognosis. International journal of molecular sciences 2017 9 18 (9): . Nørgaard Maibritt, Haldrup Christa, Storebjerg Tine Maj, Vestergaard Else Marie, Wild Peter J, Høyer Søren, Borre Michael, Ørntoft Torben Falck, Sørensen Karina Dalsgaa |
| Predicting Prostate Cancer Progression as a Function of ETS-related Gene Status, Race, and Obesity in a Longitudinal Patient Cohort. European urology focus 2017 7 4 (6): 818-824. Cullen Jennifer, Young Denise, Chen Yongmei, Degon Michael, Farrell James, Sedarsky Jason, Baptiste Wagner, Rosen Philip, Tolstikov Vladimir, Kiebish Michael, Kagan Jacob, Srivastava Sudhir, Kuo Huai-Ching, Moncur Joel T, Rosner Inger L, Narain Niven, Akmaev Viatcheslav, Petrovics Gyorgy, Dobi Albert, McLeod David G, Srivastava Shiv, Sesterhenn Isabell |
| p16 upregulation is linked to poor prognosis in ERG negative prostate cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2016 Sep 37 (9): 12655-12663. Burdelski Christoph, Dieckmann Tatsiana, Heumann Asmus, Hube-Magg Claudia, Kluth Martina, Beyer Burkhard, Steuber Thomas, Pompe Raisa, Graefen Markus, Simon Ronald, Minner Sarah, Tsourlakis Maria Christina, Koop Christina, Izbicki Jakob, Sauter Guido, Krech Till, Schlomm Thorsten, Wilczak Waldemar, Lebok Patri |
| Clinical significance of ERG rearrangement subtype and its association with increased p53 expression in Japanese and German prostate cancer. Neoplasma 2015 1 62 (2): 278-87. Nishijima J, Hara T, Ikemoto K, Oga A, Kobayashi K, Kawai Y, Matsumoto H, Nagao K, Sasaki K, Gkoleizakis V, Fichtner J, Matsuyama |
| High levels of 5-hydroxymethylcytosine (5hmC) is an adverse predictor of biochemical recurrence after prostatectomy in ERG-negative prostate cancer. Clinical epigenetics 2015 10 7 111. Strand Siri H, Hoyer Soren, Lynnerup Anne-Sofie, Haldrup Christa, Storebjerg Tine Maj, Borre Michael, Orntoft Torben F, Sorensen Karina |
| SPOP mutations in prostate cancer across demographically diverse patient cohorts. Neoplasia (New York, N.Y.) 2014 Jan 16 (1): 14-20. Blattner Mirjam, Lee Daniel J, O'Reilly Catherine, Park Kyung, MacDonald Theresa Y, Khani Francesca, Turner Kevin R, Chiu Ya-Lin, Wild Peter J, Dolgalev Igor, Heguy Adriana, Sboner Andrea, Ramazangolu Sinan, Hieronymus Haley, Sawyers Charles, Tewari Ashutosh K, Moch Holger, Yoon Ghil Suk, Known Yong Chul, Andrén Ove, Fall Katja, Demichelis Francecsa, Mosquera Juan Miguel, Robinson Brian D, Barbieri Christopher E, Rubin Mark |
| Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2013 Feb . Kluth M, Hesse J, Heinl A, Krohn A, Steurer S, Sirma H, Simon R, Mayer PS, Schumacher U, Grupp K, Izbicki JR, Pantel K, Dikomey E, Korbel JO, Plass C, Sauter G, Schlomm T, Minner S |
| Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer. The American journal of pathology 2012 Aug 181 (2): 401-12. Krohn Antje, Diedler Tobias, Burkhardt Lia, Mayer Pascale-Sophie, De Silva Colin, Meyer-Kornblum Marie, Kötschau Darja, Tennstedt Pierre, Huang Joseph, Gerhäuser Clarissa, Mader Malte, Kurtz Stefan, Sirma Hüseyin, Saad Fred, Steuber Thomas, Graefen Markus, Plass Christoph, Sauter Guido, Simon Ronald, Minner Sarah, Schlomm Thorst |
| Correlation of ERG expression and DNA methylation biomarkers with adverse clinicopathologic features of prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2012 3 18 (10): 2896-904. Kron Ken, Liu Liyang, Trudel Dominique, Pethe Vaijayanti, Trachtenberg John, Fleshner Neil, Bapat Bharati, van der Kwast Theodor |
| Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer. BMC cancer 2008 8 (1): 230. FitzGerald Liesel M, Agalliu Ilir, Johnson Karynn, Miller Melinda A, Kwon Erika M, Hurtado-Coll Antonio, Fazli Ladan, Rajput Ashish B, Gleave Martin E, Cox Michael E, Ostrander Elaine A, Stanford Janet L, Huntsman David |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: